The Patent Finder

Helix Biopharma Corp.

Also on record
Records under this name other than the patents Helix Biopharma Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to Helix Biopharma Corp.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,945,529Biphasic Lipid-Vesicle Compositions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,986,732Biphasic Lipid-Vesicle Compositions and Methods for Treating Cervical Dysplasia by Intravaginal Delivery
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,992,969Biphasic Lipid-Vesicle Compositions and Methods for Treating Cervical Dysplasia by Intravaginal Delivery
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,011,924Biphasic Lipid-Vesicle Compositions and Methods for Treating Cervical Dysplasia by Intravaginal Delivery
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,159,646Biphasic Lipid-Vesicle Compositions and Methods for Treating Cervical Dysplasia by Intravaginal Delivery
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,466,088VEGFR-2 Car Immune Cells to Treat Cancers
Lapsed on the fee record
Ended Oct 11, 2026 · High confidence
Lapsed on the fee recordEnded Oct 11, 2026High confidence
US 11,242,386CEACAM6 Car Immune Cells to Treat Cancers
Lapsed on the fee record
Ended Feb 8, 2026 · High confidence
Lapsed on the fee recordEnded Feb 8, 2026High confidence
US 7,211,250Method and Composition for Inhibiting Cancer Cell Growth
Term ended
Term ended Jul 1, 2024 · High confidence
Term endedTerm ended Jul 1, 2024High confidence
US 9,296,819Antibodies and Conjugates That Target Misfolded Prion Protein
Formerly held
Lapsed on the fee record
Ended Mar 29, 2024 · High confidence
Lapsed on the fee recordEnded Mar 29, 2024High confidence
US 7,264,800Method and Composition for Inhibiting Cancer Cell Growth
Term ended
Term ended Feb 21, 2024 · High confidence
Term endedTerm ended Feb 21, 2024High confidence
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited